Foravirumab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | rabies virus glycoprotein |
Clinical data | |
ATC code | none |
Identifiers | |
CAS Number |
944548-38-3 ![]() |
ChemSpider | none |
UNII |
377VY97V7S ![]() |
ChEMBL |
CHEMBL1743021 ![]() |
Chemical and physical data | |
Formula | C6400H9914N1718O1998S44 |
Molar mass | 144.3 kg/mol |
![]() ![]() |
Foravirumab is a monoclonal antibody for the prophylaxis of rabies.[1] It is under development by Sanofi/Crucell.[2]
References
- ↑ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ↑ Khardori, Nancy Misri (2011). Biologic Response Modifiers in Infectious Diseases, An Issue of Infectious Disease Clinics. London: Elsevier Health Sciences. p. 158. ISBN 9781455712076.
This article is issued from Wikipedia - version of the 10/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.